These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22856387)

  • 41. Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
    Kumar V; Schuck EL; Pelletier RD; Farah N; Condon KB; Ye M; Rowbottom C; King BM; Zhang ZY; Saxton PL; Wong YN
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):229-37. PubMed ID: 21698359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent.
    Al-Ghananeem AM; Albayati ZF; Malkawi A; Sonar VN; Freeman ML; Crooks PA
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):915-9. PubMed ID: 17294191
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pharmacokinetics of tebipenem pivoxil, a novel oral carbapenem antibiotic, in experimental animals].
    Kijima K; Morita J; Suzuki K; Aoki M; Kato K; Hayashi H; Shibasaki S; Kurosawa T
    Jpn J Antibiot; 2009 Jun; 62(3):214-40. PubMed ID: 19882982
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Investigation of the pharmacokinetic interaction between ritonavir and CMDCK, a new non-nucleoside reverse transcriptase inhibitor.
    Zhuang XM; Shen GL; Yuan M; Li H
    Drug Res (Stuttg); 2013 May; 63(5):237-42. PubMed ID: 23539429
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of verproside after intravenous and oral administration in rats.
    Park EJ; Lee HS; Oh SR; Lee HK; Lee HS
    Arch Pharm Res; 2009 Apr; 32(4):559-64. PubMed ID: 19407974
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment of in vitro metabolic stability, plasma protein binding, and pharmacokinetics of E- and Z-guggulsterone in rat.
    Chhonker YS; Chandasana H; Mukkavilli R; Prasad YD; Laxman TS; Vangala S; Bhatta RS
    Drug Test Anal; 2016 Sep; 8(9):966-75. PubMed ID: 26608935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Determination of arbutin in vitro and in vivo by LC-MS/MS: Pre-clinical evaluation of natural product arbutin for its early medicinal properties.
    Wang QL; Zhang PX; Shen R; Xu M; Han L; Shi X; Zhou ZR; Yang JY; Liu JQ
    J Ethnopharmacol; 2024 Aug; 330():118232. PubMed ID: 38670407
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of losartan and its metabolite, EXP3174, after intravenous and oral administration of losartan to rats with streptozotocin-induced diabetes mellitus.
    Moon CH; Lee HJ; Jung YS; Lee SH; Baik EJ
    Res Commun Mol Pathol Pharmacol; 1998 Aug; 101(2):147-58. PubMed ID: 9821211
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Physiologically based pharmacokinetic-pharmacodynamic modeling for prediction of vonoprazan pharmacokinetics and its inhibition on gastric acid secretion following intravenous/oral administration to rats, dogs and humans.
    Kong WM; Sun BB; Wang ZJ; Zheng XK; Zhao KJ; Chen Y; Zhang JX; Liu PH; Zhu L; Xu RJ; Li P; Liu L; Liu XD
    Acta Pharmacol Sin; 2020 Jun; 41(6):852-865. PubMed ID: 31969689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dose-independent pharmacokinetics of a new peroxisome proliferator-activated receptor-γ agonist, KR-62980, in Sprague-Dawley rats and ICR mice.
    Park JS; Kim MS; Song JS; Choi SH; Lee BH; Woo J; Ahn JH; Bae MA; Ahn SH
    Arch Pharm Res; 2011 Dec; 34(12):2051-8. PubMed ID: 22210030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of cysteine on the pharmacokinetics of docetaxel in rats with protein-calorie malnutrition.
    Choi YH; Yoon I; Kim YG; Lee MG
    Xenobiotica; 2012 May; 42(5):442-55. PubMed ID: 22067009
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of water deprivation on the pharmacokinetics of theophylline and one of its metabolites, 1,3-dimethyluric acid, after intravenous and oral administration of aminophylline to rats.
    Choi HD; Kang HE; Chung HJ; Bae SK; Shin KN; Lee MG
    Biopharm Drug Dispos; 2007 Nov; 28(8):445-54. PubMed ID: 17847127
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of preclinical in vitro and in vivo pharmacokinetics properties for KBP-7018, a new tyrosine kinase inhibitor candidate for treatment of idiopathic pulmonary fibrosis.
    Huang Z; Li H; Zhang Q; Tan X; Lu F; Liu H; Li S
    Drug Des Devel Ther; 2015; 9():4319-28. PubMed ID: 26273193
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of cilostazol on the pharmacokinetics of carvedilol after oral and intravenous administration in rats.
    Lim TH; Cho YA; Choi DH
    J Physiol Pharmacol; 2015 Aug; 66(4):591-7. PubMed ID: 26348083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Absorption, protein binding, pharmacokinetics and excretion of the anti-ischemic and anti-hypertensive arylpiperazine derivative CDRI-93/478 in rats.
    Lal J; Gupta RC
    Arzneimittelforschung; 2008; 58(2):62-70. PubMed ID: 18412019
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist. 1st communication: absorption and excretion in rats after a single administration of 14C-NS-49.
    Mukai H; Watanabe S; Morino A
    Arzneimittelforschung; 1999 May; 49(5):434-40. PubMed ID: 10367106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Population Pharmacokinetic Modeling of the Enterohepatic Recirculation of Fimasartan in Rats, Dogs, and Humans.
    Kim TH; Shin S; Landersdorfer CB; Chi YH; Paik SH; Myung J; Yadav R; Horkovics-Kovats S; Bulitta JB; Shin BS
    AAPS J; 2015 Sep; 17(5):1210-23. PubMed ID: 25990964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.